DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+0.28%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$35.8B
AUM Growth
+$1.5B
(+4.4%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
1,455
New
69
Increased
612
Reduced
362
Closed
87
Top Buys
| 1 |
Stellantis
STLA
|
+$102M |
| 2 |
Analog Devices
ADI
|
+$94.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$88.6M |
| 4 |
Amazon
AMZN
|
+$86.6M |
| 5 |
UnitedHealth
UNH
|
+$82.2M |
Top Sells
| 1 |
Deutsche Bank
DB
|
+$338M |
| 2 |
Wells Fargo
WFC
|
+$109M |
| 3 |
Qualcomm
QCOM
|
+$101M |
| 4 |
Linde
LIN
|
+$85.1M |
| 5 |
Baidu
BIDU
|
+$62.8M |
Sector Composition
| 1 | Technology | 26.43% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 11.31% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Sarepta Therapeutics
SRPT
$1.85B
| $3.33M | 0.01% |
37,660
-20,500
| -35% | -$1.81M |
|
627
Ascendis Pharma
ASND
$12.3B
| $3.33M | 0.01% |
21,270
| – | – |
|
628
Neurocrine Biosciences
NBIX
$14.3B
| $3.31M | 0.01% |
35,085
-718
| -2% | -$67.8K |
|
629
FirstEnergy
FE
$25B
| $3.29M | 0.01% |
90,983
+4,149
| +5% | +$150K |
|
630
Carnival Corp
CCL
$42.8B
| $3.26M | 0.01% |
126,442
+55,101
| +77% | +$1.42M |
|
631
Atlassian
TEAM
$47.8B
| $3.25M | 0.01% |
8,294
+2,584
| +45% | +$1.01M |
|
632
Idacorp
IDA
$6.73B
| $3.2M | 0.01% |
30,318
-2,449
| -7% | -$258K |
|
633
Brady Corp
BRC
$3.7B
| $3.17M | 0.01% |
61,654
+4,850
| +9% | +$250K |
|
634
Paycom
PAYC
$12.5B
| $3.17M | 0.01% |
6,378
-363
| -5% | -$180K |
|
635
Equifax
EFX
$31B
| $3.15M | 0.01% |
12,136
+948
| +8% | +$246K |
|
636
Credicorp
BAP
$20.9B
| $3.11M | 0.01% |
28,707
-1,400
| -5% | -$152K |
|
637
Lamb Weston
LW
$7.96B
| $3.11M | 0.01% |
50,444
-18,294
| -27% | -$1.13M |
|
638
Genuine Parts
GPC
$19.3B
| $3.09M | 0.01% |
25,074
+1,001
| +4% | +$123K |
|
639
Iovance Biotherapeutics
IOVA
$858M
| $3.06M | 0.01% |
127,600
| – | – |
|
640
Essential Properties Realty Trust
EPRT
$5.94B
| $3.04M | 0.01% |
107,027
+723
| +0.7% | +$20.5K |
|
641
Molina Healthcare
MOH
$9.84B
| $3.02M | 0.01% |
10,786
-777
| -7% | -$218K |
|
642
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.01M | 0.01% |
34,910
+18,000
| +106% | +$1.55M |
|
643
Ciena
CIEN
$17.3B
| $3.01M | 0.01% |
59,200
-14,861
| -20% | -$756K |
|
644
Cameco
CCJ
$33.7B
| $2.97M | 0.01% |
141,671
+1,551
| +1% | +$32.5K |
|
645
Suzano
SUZ
$11.8B
| $2.96M | 0.01% |
300,000
-150,000
| -33% | -$1.48M |
|
646
Brixmor Property Group
BRX
$8.52B
| $2.95M | 0.01% |
130,644
-1,059
| -0.8% | -$23.9K |
|
|
HRC
647
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.92M | 0.01% |
19,400
| – | – |
|
648
Fair Isaac
FICO
$37.1B
| $2.87M | 0.01% |
7,245
-3,083
| -30% | -$1.22M |
|
649
FirstService
FSV
$9.38B
| $2.85M | 0.01% |
15,745
-9,858
| -39% | -$1.78M |
|
650
TransDigm Group
TDG
$73.9B
| $2.84M | 0.01% |
4,491
-1,239
| -22% | -$783K |
|